Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 3/20 | 0.68 |
| ▸ | GRIN1 | Q05586 | 6/20 | 0.51 |
| ▸ | GRIN2A | Q12879 | 6/20 | 0.51 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.51 |
| ▸ | OSBP | P22059 | 4/20 | 0.50 |
| ▸ | OSBP2 | Q969R2 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.50 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.50 |
| ▸ | NR1H3 | Q13133 | 6/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.49 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.49 |
| ▸ | DHCR24 | Q15392 | 1/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6388188 | 1.00 | RORC (0.68) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| SCHEMBL6388335 | 1.00 | RORC (0.68) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| SCHEMBL6840972 | 1.00 | RORC (0.68) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| SCHEMBL6387084 | 0.87 | OSBP (0.67) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| SCHEMBL6387278 | 0.87 | OSBP (0.67) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| SCHEMBL6388394 | 0.87 | OSBP (0.67) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| SCHEMBL6389393 | 0.87 | OSBP (0.67) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| SCHEMBL15004641 | 0.85 | RORC (0.66) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| SCHEMBL6386385 | 0.85 | RORC (0.79) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| SCHEMBL6393174 | 0.85 | RORC (0.79) | RORCGRIN1GRIN2AGRIN2BOSBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050004382-A1 | Meiosis regulating compounds | GRONDAHL CHRISTIAN (DK) | 2005-01-06 | — | — | US | disclosed |
| EP-0946584-B1 | Meiosis regulating compounds | NOVO NORDISK AS (DK) | 2003-04-23 | — | — | EP | disclosed |
| US-6486145-B2 | STEROL DERIVATIVE USEFUL IN TREATMENT OF FERTILITY | NOVO NORDISK A/S (DK) | 2002-11-26 | — | — | US | disclosed |
| US-20010005757-A1 | Meiosis regulating compounds | GRONDAHL CHRISTIAN (DK) | 2001-06-28 | — | — | US | disclosed |
| EP-0946584-A1 | MEIOSIS REGULATING COMPOUNDS | NOVO NORDISK A/S (DK) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998028323-A1 | MEIOSIS REGULATING COMPOUNDS | NOVO NORDISK A/S (DK) | 1998-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010005757-A1 | Meiosis regulating compounds | MNS1, NR5A1, NASP | RORC 1053/4885GRIN1 4263/4885GRIN2A 4663/4885 |
| US-20050004382-A1 | Meiosis regulating compounds | NASP, MNS1, NR5A1 | RORC 687/4885GRIN1 4613/4885GRIN2A 4630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.